71 related articles for article (PubMed ID: 15963498)
41. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma.
Xu XQ; Emerald BS; Goh EL; Kannan N; Miller LD; Gluckman PD; Liu ET; Lobie PE
J Biol Chem; 2005 Jun; 280(25):23987-4003. PubMed ID: 15845533
[TBL] [Abstract][Full Text] [Related]
42. [Advances in the study of proto-oncogene c-erbB-2].
Jiang K; Tong T
Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):158-60. PubMed ID: 8758451
[No Abstract] [Full Text] [Related]
43. Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression.
White SL; Gharbi S; Bertani MF; Chan HL; Waterfield MD; Timms JF
Br J Cancer; 2004 Jan; 90(1):173-81. PubMed ID: 14710226
[TBL] [Abstract][Full Text] [Related]
44. Hormonal control of growth factor receptor expression.
De Bortoli M; Maggiora P; Capello D; Antoniotti S; Saviozzi S; Sapei ML; Dati C
Ann N Y Acad Sci; 1996 Apr; 784():336-48. PubMed ID: 8651582
[TBL] [Abstract][Full Text] [Related]
45. Systematic variation in gene expression patterns in human cancer cell lines.
Ross DT; Scherf U; Eisen MB; Perou CM; Rees C; Spellman P; Iyer V; Jeffrey SS; Van de Rijn M; Waltham M; Pergamenschikov A; Lee JC; Lashkari D; Shalon D; Myers TG; Weinstein JN; Botstein D; Brown PO
Nat Genet; 2000 Mar; 24(3):227-35. PubMed ID: 10700174
[TBL] [Abstract][Full Text] [Related]
46. Human papilloma virus and breast cancer.
Altundag K; Altundag O; Gundeslioglu O
J Clin Virol; 2005 Jun; 33(2):179. PubMed ID: 15911436
[No Abstract] [Full Text] [Related]
47. Integrated systems pharmacology analysis of clinical drug-induced peripheral neuropathy.
Hur J; Guo AY; Loh WY; Feldman EL; Bai JP
CPT Pharmacometrics Syst Pharmacol; 2014 May; 3(5):e114. PubMed ID: 24827872
[TBL] [Abstract][Full Text] [Related]
48. [Neuregulin 2 is highly expressed in glioma tissues to regulate glial fibrillary acidic protein expression
Zhao W; Lin J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1171-1176. PubMed ID: 34549707
[TBL] [Abstract][Full Text] [Related]
49. Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration.
Li R; Li DH; Zhang HY; Wang J; Li XK; Xiao J
Acta Pharmacol Sin; 2020 Oct; 41(10):1289-1300. PubMed ID: 32123299
[TBL] [Abstract][Full Text] [Related]
50. Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway.
Wang Y; Ning Z; Zhou X; Yang Z; Tang H; Xu M; Wang X; Zhao J; Bai Y
J Thorac Dis; 2018 Jun; 10(6):3166-3179. PubMed ID: 30069312
[TBL] [Abstract][Full Text] [Related]
51. Characterization of a P-Rex1 gene signature in breast cancer cells.
Barrio-Real L; Wertheimer E; Garg R; Abba MC; Kazanietz MG
Oncotarget; 2016 Aug; 7(32):51335-51348. PubMed ID: 27351228
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
[TBL] [Abstract][Full Text] [Related]
53. Molecular modeling of ErbB4/HER4 kinase in the context of the HER4 signaling network helps rationalize the effects of clinically identified HER4 somatic mutations on the cell phenotype.
Telesco SE; Vadigepalli R; Radhakrishnan R
Biotechnol J; 2013 Dec; 8(12):1452-64. PubMed ID: 24318637
[TBL] [Abstract][Full Text] [Related]
54. The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.
Chua YL; Ito Y; Pole JC; Newman S; Chin SF; Stein RC; Ellis IO; Caldas C; O'Hare MJ; Murrell A; Edwards PA
Oncogene; 2009 Nov; 28(46):4041-52. PubMed ID: 19802002
[TBL] [Abstract][Full Text] [Related]
55. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.
de Bont JM; Packer RJ; Michiels EM; den Boer ML; Pieters R
Neuro Oncol; 2008 Dec; 10(6):1040-60. PubMed ID: 18676356
[TBL] [Abstract][Full Text] [Related]
56. Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons.
Honjo Y; Kniss J; Eisen JS
Development; 2008 Aug; 135(15):2615-25. PubMed ID: 18599505
[TBL] [Abstract][Full Text] [Related]
57. Neuregulin-regulated gene expression in mammary carcinoma cells.
Amin DN; Tuck D; Stern DF
Exp Cell Res; 2005 Sep; 309(1):12-23. PubMed ID: 15963498
[TBL] [Abstract][Full Text] [Related]
58. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
[TBL] [Abstract][Full Text] [Related]
59. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
[TBL] [Abstract][Full Text] [Related]
60. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells.
Li Q; Ahmed S; Loeb JA
Cancer Res; 2004 Oct; 64(19):7078-85. PubMed ID: 15466203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
